BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. EGFR, glucose metabolic process, Leukemia, Hippocampus, Anticancer prodrugs)
Bookmark Forward

QuickView for smoothened binding (biogroup)


Body Atlas

Most Correlated Tissues

  1. Spleen
  2. Omental adipose tissue
  3. Esophagus
  4. Frontal lobe
  5. Hypothalamus
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Bardet-Biedl syndrome
  2. Contact dermatitis
  3. Waardenburg's syndrome
  4. Holoprosencephaly sequence
  5. Sepsis due to Streptococcus agalactiae
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. AZD8055
  2. Sonic Hedgehog Protein
  3. Apitolisib
  4. pazopanib
  5. CP 466722
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. osm-11
  2. TCIRG1
  3. BAZ1B
  4. GLI2
  5. NIPSNAP1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. OMIM - Cancer
  2. OMIM - Malignant neoplasms
  3. L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
  4. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
  5. Back skin biopsies from different male or female mice strains treated with imiquimod (or Aldara TM)
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. GRIFFIN: a system for predicting GPCR-G-protein coupling selectivity using a support vector machine …
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcin…
  2. FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
  3. Topical Metformin Emulgel VS Salicylic Acid Peeling in Treatment of Acne Vulgaris
  4. Vismodegib for Treatment of Basal Cell Carcinoma
  5. Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.